Perspective Therapeutics
CATX
CATX
39 hedge funds and large institutions have $5.79M invested in Perspective Therapeutics in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Holders
39
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$76.4K | |
| 2 | +$46K | |
| 3 | +$18.2K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$12.6K |
| 5 |
Two Sigma Advisers
New York
|
+$9.56K |
Top Sellers
| 1 | -$377K | |
| 2 | -$204K | |
| 3 | -$56.5K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$24K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$22K |